Study requires patients for new type of silicone-gel breast implants

NewsGuard 100/100 Score

Researchers at UT Southwestern Medical Center at Dallas are looking for women to participate in the second phase of a study of a new cohesive silicone-gel breast implant.

The implant, which has the consistency of a "gummy candy," is made of a cohesive silicone gel that will not leak if the implant breaks, said Dr. William P. Adams Jr., associate professor of plastic surgery at UT Southwestern. Cohesive-gel implants have been the most widely used type of breast implant in Europe and Brazil for about a decade due to their cosmetic and safety benefits.

"This new implant is made of a different kind of silicone, with molecules cross-linked to give a thicker consistency producing a form-stable implant," Dr. Adams said. "This unique filler produces superior shaping, and the gel won't migrate if the shell breaks, offering potential safety benefits not available with previous gel implants."

UT Southwestern completed the first phase of a yearlong clinical trial on the product in December, with positive preliminary results, Dr. Adams said.

"There is no perfect implant," he said. "But this one is a big step in that direction, with preliminary results better than any other implant data we've seen. It offers an improved option for patients wanting either reconstructive or cosmetic surgery."

UT Southwestern researchers are looking for women 18 years or older who are considering breast augmentation, implant revision or breast reconstruction. If interested, please call 214-648-2290.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers identify increased brain tumor risk with specific contraceptive use